Risks include IV complications, allergic reactions, dosing uncertainty, and quality problems when a compounded sterile ingredient is contaminated or unsuitable for injection
4.7 Combined use of SGLT2i and GLP-1 RAs Several studies have explored the combination of GLP-1 RAs and SGLT-2 inhibitors in patients with T2DM
Call to Action If you're experiencing fatigue, stubborn weight gain, poor recovery, or other signs of low GH, it may be time to evaluate your growth hormone function
Given that there is currently no drug to treat long COVID despite more than $1 billion in spending on research by the federal government, the possibility that GLP-1 drugs are beneficial in this domain is extremely appealing
KawamuraNShinodaKSatoHSasakiKSuzukiMYamakiKet alPlasma metabolome analysis of patients with major depressive disorder
The STEP trials, which followed over 4,500 patients receiving semaglutide injections weekly, demonstrated average weight loss of 1522% of body weight at the highest doses